Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19,588 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of olmesartan medoxomil‑amlodipine besylate tablets (Sevikar®) in older patients with essential hypertension: Subgroup analysis from the Sevikar study.
Cui Z, Qiu Z, Cheng W, Hu W, Ma G, Cai X, Jin Y, Zhao Y, He L, Li Y, Bu P, Chen X, Wang R, Chen L, Dong P, Feng L, Han X, Hong M, Hou Y, Liao M, Wang M, Wang X, Xie J, Xu Y, Wang Z, Huang K, Li Y, Li D, Ji X, Huang J, Wang J, Fang D, Wang J, Tang L, Liu Y, Fu G, Du J, Wang L, Liu M, Ge J. Cui Z, et al. Among authors: han x. Exp Ther Med. 2023 Dec 5;27(2):51. doi: 10.3892/etm.2023.12338. eCollection 2024 Feb. Exp Ther Med. 2023. PMID: 38234624 Free PMC article.
Efficacy and safety of olmesartan medoxomil-amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single-arm, multi-center, real-world study.
Cui Z, Qiu Z, Cheng W, Hu W, Ma G, Cai X, Jin Y, Zhao Y, He L, Li Y, Bu P, Chen X, Wang R, Chen L, Dong P, Feng L, Han X, Hong M, Hou Y, Liao M, Wang M, Wang X, Xie J, Xu Y, Wang Z, Huang K, Li Y, Li D, Ji X, Huang J, Wang J, Fang D, Wang J, Tang L, Liu Y, Fu G, Du J, Wang L, Liu M, Ge J. Cui Z, et al. Among authors: han x. J Clin Hypertens (Greenwich). 2024 Jan;26(1):5-16. doi: 10.1111/jch.14700. Epub 2023 Sep 4. J Clin Hypertens (Greenwich). 2024. PMID: 37667532 Free PMC article.
Performance of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) in Chinese Population with Primary Prevention Indications: A Prospective Observational Cohort Study.
Li Y, Chen Y, Wang J, Xu J, Li R, Qiu Z, Jiang L, Shen F, Jiang S, Li B, Chu Y, He L, Pu L, Han X, Long X, Xue X, Tao J, Wu Y, Guo T, Yuan Y, Wang X, Wang J, Xu J, Zhao Y, Zhang Z, Hua W, Su Y, Tang B. Li Y, et al. Among authors: han x. Med Sci Monit. 2024 Feb 24;30:e942747. doi: 10.12659/MSM.942747. Med Sci Monit. 2024. PMID: 38400538 Free PMC article.
Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2).
Chai M, He Y, Zhao W, Han X, Zhao G, Ma X, Qiao P, Shi D, Liu Y, Han W, An P, Li H, Yan S, Ma Q, Deng H, Qian L, Zhou Y; CREDIT-2 investigators. Chai M, et al. Among authors: han x, han w. BMC Med. 2023 Feb 28;21(1):77. doi: 10.1186/s12916-023-02797-8. BMC Med. 2023. PMID: 36855099 Free PMC article. Clinical Trial.
19,588 results
You have reached the last available page of results. Please see the User Guide for more information.